Institute for Biohealth Innovation

This month, a new Northern Virginia International Soft-Landing Accelerator (NISA) program, designed to help start-ups from around the globe find guidance, connections, and lab or office spaces at no cost, was launched to help develop new technologies in life sciences.

Researchers in George Mason’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study, published in Nature’s Gene Therapy, that found a human immunodeficiency virus (HIV)-like virus particle that could cease the need for lifelong medications.

With the opening of the Nanofabrication Facility on its Science and Technology Campus, Mason stands ready to conduct state-of-the-art research and to help train the next generation of innovators.

U.S. Congresswoman Jennifer Wexton toured Mason’s Science and Technology Campus on Tuesday, August 29.

Probiotic supplementation staved off the negative effects associated with a high-fat diet, illustrating how probiotics may play a key role in preventative health care, George Mason study indicates.

In partnership with Phoenix Advantage, a Virginia-based economic development and business consulting firm, Caroline Sutter of Mason’s College of Public Health; Amy Adams, executive director of the Institute for Biohealth Innovation; and their team have received a life science talent pathway planning grant from GO Virginia, a state-funded initiative administered by the Virginia Department of Housing and Community Development.

Mason infectious disease researcher Aarthi Narayanan has partnered with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and Cyclica, a biotechnology company based in Canada, to identify potential broad-spectrum therapeutics for illnesses triggered by HFVs and similar pathogens.

With the support of her Mason mentors, doctoral student Shrishti Singh has achieved her goal of developing a promising new technology that would allow cancer to be visualized in deep tissue and perhaps diagnosed earlier.

A George Mason University team led by Alessandra Luchini and Lance Liotta has been named one of 10 Phase 1 winners of the LymeX Diagnostics Prize by the U.S. Department of Health and Human Services (HHS) and the Steven and Alexandra Cohen Foundation.

The NSF Research Traineeship Program program was established in 2019 with a five-year grant of nearly $3 million from the National Science Foundation and is preparing an interdisciplinary, community-engaged STEM workforce with the expertise necessary for cross-disciplinary collaboration.